Crystal structure of the biologically active form of class Ib ribonucleotide reductase small subunit from Mycobacterium tuberculosis

FEBS Letters
Malin UppstenUlla Uhlin

Abstract

Two nrdF genes of Mycobacterium tuberculosis code for different R2 subunits of the class Ib ribonucleotide reductase (RNR). The proteins are denoted R2F-1 and R2F-2 having 71% sequence identity. The R2F-2 subunit forms the biologically active RNR complex with the catalytic R1E-subunit. We present the structure of the reduced R2F-2 subunit to 2.2 A resolution. Comparison of the R2F-2 structure with a model of R2F-1 suggests that the important differences are located at the C-terminus. We found that within class Ib, the E-helix close to the iron diiron centre has two preferred conformations, which cannot be explained by the redox-state of the diiron centre. In the R2F-2 structure, we also could see a mobility of alphaE in between the two conformations.

References

Jan 1, 1979·Annual Review of Biochemistry·L Thelander, P Reichard
Mar 1, 1991·Acta Crystallographica. Section A, Foundations of Crystallography·T A JonesM Kjeldgaard
Jan 1, 1991·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·G CosentinoN Dansereau
Dec 1, 1985·Environmental Health Perspectives·A GräslundB M Sjöberg
Oct 20, 1995·Science·C M FraserJ C Venter
Aug 18, 1994·Nature·U Uhlin, H Eklund
Jan 1, 1996·Annual Review of Biophysics and Biomolecular Structure·A Gräslund, M Sahlin
Oct 25, 1996·The Journal of Biological Chemistry·R EliassonP Reichard
Mar 25, 1999·Acta Crystallographica. Section D, Biological Crystallography·A A VaguineS J Wodak
Mar 25, 1999·Acta Crystallographica. Section D, Biological Crystallography·G J Kleywegt, T A Jones
Feb 14, 2002·Progress in Biophysics and Molecular Biology·H EklundP Nordlund
Feb 19, 2002·Chemical Reviews·JoAnne Stubbe, Wilfred A. van Der Donk
Jun 26, 2003·Nucleic Acids Research·Torsten SchwedeManuel C Peitsch
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
Jul 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·A PerrakisV S Lamzin
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G N MurshudovE J Dodson
Jan 1, 1997·Methods in Enzymology·Zbyszek Otwinowski, Wladek Minor

❮ Previous
Next ❯

Citations

Mar 27, 2012·Biochemistry·Amie K BoalAmy C Rosenzweig
Sep 3, 2009·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Hideaki OgataWolfgang Lubitz
Aug 7, 2010·Science·Amie K BoalAmy C Rosenzweig
Dec 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eduard TorrentsBritt-Marie Sjöberg
Mar 4, 2014·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Marta HammerstadK Kristoffer Andersson
Dec 4, 2013·ACS Chemical Biology·Marta HammerstadK Kristoffer Andersson
Aug 12, 2015·Journal of Biochemistry·Naoki Shibata, Tetsuo Toraya
Aug 15, 2006·Current Opinion in Pharmacology·Khisimuzi Mdluli, Melvin Spigelman
Oct 20, 2018·Journal of Biomolecular Structure & Dynamics·Yueqi WangDong-Qing Wei
Jan 5, 2011·Protein & Cell·Zhiyong Lou, Xiaoxue Zhang
Aug 15, 2019·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Kristīne GrāveMartin Högbom
Aug 16, 2006·Accounts of Chemical Research·Matthew H Sazinsky, Stephen J Lippard
Apr 1, 2017·Microbiology Spectrum·Zanele DitseDigby F Warner
Aug 31, 2021·The Journal of Biological Chemistry·Terry B Ruskoski, Amie K Boal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.